Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Schnierle

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytesS Thaler, B S Schnierle
Gene Therapy|December 1, 1996
Retroviral targeted deliveryB S Schnierle, B Groner
Virology|June 1, 1992
Vaccinia virus-mediated inhibition of host protein synthesis involves neither degradation nor underphosphorylation of components of the cap-binding eukaryotic translation initiation factor complex eIF-4FB S Schnierle, B Moss
The Journal of Biological Chemistry|August 12, 1994
Mutational analysis of a multifunctional protein, with mRNA 5' cap-specific (nucleoside-2'-O-)-methyltransferase and 3'-adenylyltransferase stimulatory activities, encoded by vaccinia virusB S Schnierle, P D Gershon, B Moss
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single proteinB S Schnierle, P D Gershon, B Moss
Journal of Virological Methods|September 17, 1999
Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particlesB Gerstmayer, B Groner, W Wels, et al.
Gene Therapy|April 1, 1996
Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particlesB S Schnierle, D Moritz, M Jeschke, et al.
Virology|August 12, 1999
Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particlesM Höhne, S Thaler, J C Dudda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytesU Altenschmidt, R Kahl, D Moritz, et al.
Clinical and Experimental Immunology|April 24, 2013
Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cellsS M Büchner, K Sliva, H Bonig, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytesS Thaler, B S Schnierle
Gene Therapy|December 1, 1996
Retroviral targeted deliveryB S Schnierle, B Groner
Virology|June 1, 1992
Vaccinia virus-mediated inhibition of host protein synthesis involves neither degradation nor underphosphorylation of components of the cap-binding eukaryotic translation initiation factor complex eIF-4FB S Schnierle, B Moss
The Journal of Biological Chemistry|August 12, 1994
Mutational analysis of a multifunctional protein, with mRNA 5' cap-specific (nucleoside-2'-O-)-methyltransferase and 3'-adenylyltransferase stimulatory activities, encoded by vaccinia virusB S Schnierle, P D Gershon, B Moss
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single proteinB S Schnierle, P D Gershon, B Moss
Journal of Virological Methods|September 17, 1999
Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particlesB Gerstmayer, B Groner, W Wels, et al.
Gene Therapy|April 1, 1996
Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particlesB S Schnierle, D Moritz, M Jeschke, et al.
Virology|August 12, 1999
Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particlesM Höhne, S Thaler, J C Dudda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytesU Altenschmidt, R Kahl, D Moritz, et al.
Clinical and Experimental Immunology|April 24, 2013
Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cellsS M Büchner, K Sliva, H Bonig, et al.
Pageof 2